The Intercontinental Journal of Internal Medicine aims to publish issues related to all fields of internal medicine of the highest scientific and clinical value at an international level and accepts articles on these topics.

EndNote Style
Current approach to diabetic polyneuropathy: current diagnosis and treatment
Diabetes mellitus and its associated neuropathy are among the leading problems affecting the quality of life negatively. Diabetic foot problems due to neuropathy cause very serious problems. Physicians may focus too much on blood sugar regulation and ignore examinations for other macro and microvascular complications of diabetes. Although it appears earlier in patients with impaired blood sugar regulation, neuropathic symptoms are seen in almost half of diabetic patients who generally exceed 10 years. With early diagnosis and treatment, the quality of life of patients increases significantly. We touched on this issue in order to raise awareness of neuropathy, which is so common.

1. Zheng Y, Ley SH, Hu FB. Global aetiologyandepidemiology oftype 2 diabetes mellitus and its complications. Nat Rev Endocrinol.2018;14(2):88-98.
2. Holman N, Young B, Gadsby R. Current prevalence of type 1 and type 2diabetes in adults and children in the UK. Diabet Med. 2015;32(9):1119-1120.
3. Bruno G,Runzo C, Cavallo-Perin P, et al; Piedmont Study Group forDiabetes Epidemiology. Incidence of type 1 and type 2 diabetes inadults aged 30-49 years: the population-based registry in the provinceof Turin, Italy.Diabetes Care. 2005;28(11):2613-2619.
4. Tinajero MG, Malik VS. An update on the epidemiology of type 2diabetes: a global perspective. Endocrinol Metab Clin North Am.2021;50(3):337-355.
5. Russell JW, Zilliox LA. Diabetic neuropathies.Continuum: lifelong learning in neurology. Peripheral Nervous System Disorders.2014;20(5):1226-1240.
6. Ziegler D, Keller J, Maier C, Pannek J.Diabetic Neuropathy. Exp ClinEndocrinol Diabetes. 2023;131(1-02):72-83.
7. Brown MJ,Asbury AK. Diabetic neuropathy.AnnNeurol.1984;15(1):2-12.
8. Zochodne DW. Diabetic neuropathies: features and mechanisms.BrainPathol.1999;9(2):369-391.
9. Pop-Busui R,Boulton AJM,Feldman EL,et al. Diagnosis and treatmentof painful diabetic neuropathy.ADA Clin Compend Ser.2022;2022:1-32.
10. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severityof various types of diabetic neuropathy, retinopathy, andnephropathyin a population-based cohort: the Rochester Diabetic NeuropathyStudy. Neurology. 1993;43(4):817-824.
11. Llewelyn JG, Tomlinson DR, Thomas PK. Diabetic neuropathies.InPeripheral Neuropathy. 4th ed. Dyck PJ, Thomas PK, Eds.Philadelphia, Elsevier. 2005, p. 1951-1992.
12. Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton LJ 3rd, O’BrienPC. Risk factors for severity of diabetic polyneuropathy: intensive longattitudinal assessment of the Rochester Diabetic Neuropathy Studycohort. Diabetes Care. 1999;22(9):1479-1486.
13. Tesfaye S, Chaturvedi N, Eaton SE, et al; EURODIAB ProspectiveComplications Study Group. Vascular risk factors and diabeticneuropathy. N Engl J Med. 2005;352(4):341-350.
14. Dyck PJ, Davies JL, Clark VM, et al.Modeling chronic glycemicexposure variables as correlates and predictors of microvascularcomplications of diabetes. Diabetes Care. 2006;29(10):2282-2288.
15. Thomas PK. Classification, differential diagnosis and staging of diabeticperipheral neuropathy. Diabetes. 1997;46(Suppl.2):S54-S57.
16. Boulton AJ, Vinik AI, Arezzo JC, et al;American Diabetes Association.Diabetic neuropathies: a statement by the American DiabetesAssociation. Diabetes Care. 2005;28(4):956-962.
17. Archer AG, Watkins PJ, Thomas PK, Sharma AK, Payan J. The naturalhistory of acute painful neuropathy in diabetes mellitus. J NeurolNeurosurg Psychiatry. 1983;46(6):491-499.
18. Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies: update ondefinitions, diagnosticcriteria, estimation of severity, and treatments.Diabetes Care. 2010;33(10):2285-2293.
19. Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy.Nat Rev Dis Primers. 2019;5(1):41.
20. Albers JW, Pop-Busui R. Diabetic neuropathy: mechanisms, emergingtreatments, and subtypes. Curr Neurol Neurosci Rep. 2014;14(8):473.
21. Callaghan BC, Kerber KA, Lisabeth LL, et al. Role of neurologistsand diagnostic tests on the management of distal symmetric polyneuropathy. JAMA Neurol. 2014;71(9):1143-1149.
22. Dyck PJ, Albers JW, Andersen H, et al. Toronto Expert Panel onDiabetic Neuropathy. Diabetic polyneuropathies: update on researchdefinition, diagnostic criteria and estimation of severity. DiabetesMetab Res Rev. 2011;27(7):620-628.
23. Malik RA, Veves A, Tesfaye S, et al. Toronto Consensus Panel onDiabetic Neuropathy. Small fibre neuropathy: role in the diagnosisof diabetic sensorimotor polyneuropathy. Diabetes Metab Res Rev.2011;27(7):678-684.
24. Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic neuropathy: aposition statement by the American Diabetes Association. DiabetesCare. 2017;40(1):136-154.
25. Feldman EL.Pathogenesis of diabetic polyneuropathy. [UpToDate]
26. Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabeticneuropathy: Where are wenow and where to go? J DiabetesInvestig.2011;2(1):18-32.
27. Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinicalmanagement of diabetic sensorimotor peripheral neuropathy. Nat RevEndocrinol. 2021;17(7):400- 420
28. Feldman EL. Screening for diabetic polyneuropathy. [UpToDate]
29. American Diabetes Association Professional Practice Committee; 12.Retinopathy, Neuropathy, and Foot Care: Standards of MedicalCare inDiabetes-2022. Diabetes Care. 2022;45(Suppl 1):S185-S194.
30. Kaku M, Vinik A, Simpson DM. Pathways in the diagnosis andmanagement of diabetic polyneuropathy. Curr Diab Rep. 2015;15(6):609
31. Feldman EL. Management of diabetic neuropathy. [UpToDate]
32. Khdour MR. Treatment of diabetic peripheralneuropathy: a review. JPharm Pharmacol. 2020;72(7):863-872
Volume 1, Issue 3, 2023
Page : 66-70